170 related articles for article (PubMed ID: 8494604)
1. Binding to DNA, cellular uptake and biological activity of a distamycin-ellipticine hybrid molecule.
Bailly C; Leclere V; Pommery N; Colson P; Houssier C; Rivalle C; Bisagni E; Hénichart JP
Anticancer Drug Des; 1993 Apr; 8(2):145-64. PubMed ID: 8494604
[TBL] [Abstract][Full Text] [Related]
2. DNA-binding properties of a distamycin-ellipticine hybrid molecule.
Bailly C; O'Huigin C; Houssin R; Colson P; Houssier C; Rivalle C; Bisagni E; Henichart JP; Waring MJ
Mol Pharmacol; 1992 May; 41(5):845-55. PubMed ID: 1588919
[TBL] [Abstract][Full Text] [Related]
3. Reaction of a biscationic distamycin-ellipticine hybrid ligand with DNA. Mode and sequence specificity of binding.
Bailly C; Michaux C; Colson P; Houssier C; Sun JS; Garestier T; Hélène C; Hénichart JP; Rivalle C; Bisagni E
Biochemistry; 1994 Dec; 33(51):15348-64. PubMed ID: 7803398
[TBL] [Abstract][Full Text] [Related]
4. Binding of a distamycin-ellipticine hybrid molecule to DNA and chromatin: spectroscopic, biochemical, and molecular modeling investigations.
Bourdouxhe C; Colson P; Houssier C; Sun JS; Montenay-Garestier T; Hélène C; Rivalle C; Bisagni E; Waring MJ; Hénichart JP
Biochemistry; 1992 Dec; 31(49):12385-96. PubMed ID: 1463725
[TBL] [Abstract][Full Text] [Related]
5. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
Riou JF; Grondard L; Naudin A; Bailly C
Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
[TBL] [Abstract][Full Text] [Related]
6. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
Bailly C; Hénichart JP; Colson P; Houssier C
J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
[TBL] [Abstract][Full Text] [Related]
7. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
8. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, DNA binding, and cleaving properties of an ellipticine-salen.copper conjugate.
Routier S; Bernier JL; Catteau JP; Colson P; Houssier C; Rivalle C; Bisagni E; Bailly C
Bioconjug Chem; 1997; 8(6):789-92. PubMed ID: 9404650
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate.
Boitte N; Pommery N; Colson P; Houssier C; Waring MJ; Hénichart JP; Bailly C
Anticancer Drug Des; 1997 Sep; 12(6):481-501. PubMed ID: 9311557
[TBL] [Abstract][Full Text] [Related]
12. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
Cline SD; Macdonald TL; Osheroff N
Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
[TBL] [Abstract][Full Text] [Related]
13. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.
Lansiaux A; Tanious F; Mishal Z; Dassonneville L; Kumar A; Stephens CE; Hu Q; Wilson WD; Boykin DW; Bailly C
Cancer Res; 2002 Dec; 62(24):7219-29. PubMed ID: 12499262
[TBL] [Abstract][Full Text] [Related]
14. [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Leoni A; Bianchi N; Feriotto G; Rutigliano C; Mischiati C; Gambari R
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1219-29. PubMed ID: 11097052
[TBL] [Abstract][Full Text] [Related]
15. The orientation of norfloxacin bound to double-stranded DNA.
Bailly C; Colson P; Houssier C
Biochem Biophys Res Commun; 1998 Feb; 243(3):844-8. PubMed ID: 9501014
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
Sorace RA; Sheid B
Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
[No Abstract] [Full Text] [Related]
17. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
18. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
Faddeeva MD; Beliaeva TN
Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of ellipticine and aza-analogue derivatives on cell cycle progression and survival of BALB/c 3T3 cells released from serum starvation or thymidine double block.
Vilarem MJ; Charcosset JY; Primaux F; Gras MP; Calvo F; Larsen CJ
Cancer Res; 1985 Aug; 45(8):3906-11. PubMed ID: 4016757
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
